MGIM
CTSO icon

M&G Investment Management’s Cytosorbents Corp CTSO Stock Holding History

M&G Investment Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-205,801
Closed -$1.65K – 551
2021
Q3 		$1.65K Buy
205,801
+55,657
+37% +$452K ﹤0.01% 542
2021
Q2 		$1.2K Buy
+150,144
New +$1.27M ﹤0.01% 605

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&G Investment Management's CTSO Position: Q4 2021 in Review

M&G Investment Management sold out of Cytosorbents Corp (CTSO) in Q4 2021, closing a stake of 205,801 shares — an estimated $1.65K sold.

M&G Investment Management first reported a position in CTSO in Q2 2021 and held it in 2 quarters. The position peaked at $1.65K in Q3 2021. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

  • M&G Investment Management reported no remaining Cytosorbents Corp position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 205,801 Cytosorbents Corp shares in Q4 2021, an estimated $1.65K.
  • M&G Investment Management first reported a position in Cytosorbents Corp in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Cytosorbents Corp position peaked at $1.65K in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.